Cargando…

Prognostic and predictive value of radiomic signature in stage I lung adenocarcinomas following complete lobectomy

BACKGROUND: The overall survival (OS) of stage I operable lung cancer is relatively low, and not all patients can benefit from adjuvant chemotherapy. This study aimed to develop and validate a radiomic signature (RS) for prediction of OS and adjuvant chemotherapy candidates in stage I lung adenocarc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nie, Wei, Tao, Guangyu, Lu, Zhenghai, Qian, Jie, Ge, Yaqiong, Wang, Shuyuan, Zhang, Xueyan, Zhong, Hua, Yu, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331779/ https://www.ncbi.nlm.nih.gov/pubmed/35902907 http://dx.doi.org/10.1186/s12967-022-03547-9

Ejemplares similares

Prognostic and predictive value of radiomics signatures in stage I‐III colon cancer
por: Dai, Weixing, et al.
Publicado: (2020)

Prognostic Value of CT Radiomic Features in Resectable Pancreatic Ductal Adenocarcinoma
por: Khalvati, Farzad, et al.
Publicado: (2019)

Prognostic factors for long‐term survival following complete resection by lobectomy in stage I non‐small cell lung cancer
por: Galata, Christian, et al.
Publicado: (2022)

Prognostic signature of lipid metabolism associated LncRNAs predict prognosis and treatment of lung adenocarcinoma
por: Zhao, Jie, et al.
Publicado: (2022)

Exploration and validation of radiomics signature as an independent prognostic biomarker in stage III-IVb nasopharyngeal carcinoma
por: Ouyang, Fu-Sheng, et al.
Publicado: (2017)

Identification of four differentially methylated genes as prognostic signatures for stage I lung adenocarcinoma
por: Luo, Wei-Ming, et al.
Publicado: (2018)

Robot-assisted lobectomy versus completely portal robotic lobectomy: What is the difference?
por: Akkuş, Murat, et al.
Publicado: (2020)

Radiomics Signature to Predict Prognosis in Early-Stage Lung Adenocarcinoma (≤3 cm) Patients with No Lymph Node Metastasis
por: Zhang, Li, et al.
Publicado: (2022)

Completion lobectomy after anatomical segmentectomy
por: Takamori, Satoshi, et al.
Publicado: (2021)

The Value of CT-Based Radiomics for Predicting Spread Through Air Spaces in Stage IA Lung Adenocarcinoma
por: Han, Xiaoyu, et al.
Publicado: (2022)

Prognostic and Predictive Value of Three DNA Methylation Signatures in Lung Adenocarcinoma
por: Wang, Yanfang, et al.
Publicado: (2019)

A Distinct Glucose Metabolism Signature of Lung Adenocarcinoma With Prognostic Value
por: Li, Ding, et al.
Publicado: (2022)

The prognostic value of CT radiomic features for patients with pulmonary adenocarcinoma treated with EGFR tyrosine kinase inhibitors
por: Kim, Hyungjin, et al.
Publicado: (2017)

Prognostic and predictive value of radiomics features at MRI in nasopharyngeal carcinoma
por: Bao, Dan, et al.
Publicado: (2021)

Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma
por: Chen, Dung-Tsa, et al.
Publicado: (2015)

Prognostic Value of Tumor Budding in Early-Stage Cervical Adenocarcinomas
por: Satabongkoch, Nopporn, et al.
Publicado: (2017)

Decoding tumor mutation burden and driver mutations in early stage lung adenocarcinoma using CT‐based radiomics signature
por: Wang, Xiaoxiao, et al.
Publicado: (2019)

MRI‐based radiomic signatures for pretreatment prognostication in cervical cancer
por: Wagner‐Larsen, Kari S., et al.
Publicado: (2023)

Prediction of the Growth Rate of Early-Stage Lung Adenocarcinoma by Radiomics
por: Tan, Mingyu, et al.
Publicado: (2021)

Outcomes of completion lobectomy long after segmentectomy
por: Takahashi, Yuki, et al.
Publicado: (2019)

The Prognostic Signature and Therapeutic Value of Phagocytic Regulatory Factors in Prostate Adenocarcinoma (PRAD)
por: Xin, Shiyong, et al.
Publicado: (2022)

Prognostic Value, Immune Signature, and Molecular Mechanisms of the PHLDA Family in Pancreatic Adenocarcinoma
por: Duan, Yunjie, et al.
Publicado: (2022)

Prognostic value, immune signature and molecular mechanisms of the SUMO family in pancreatic adenocarcinoma
por: Duan, Yunjie, et al.
Publicado: (2022)

Identification of Bone Metastatic and Prognostic Alternative Splicing Signatures in Prostate Adenocarcinoma
por: Zhu, Jiwen, et al.
Publicado: (2023)

A robust prognostic gene expression signature for early stage lung adenocarcinoma
por: Krzystanek, Marcin, et al.
Publicado: (2016)

Thoracoscopic Lobectomy versus Open Lobectomy in Stage I Non-Small Cell Lung Cancer: A Meta-Analysis
por: Cai, Yi-xin, et al.
Publicado: (2013)

Prognostic Value and Genome Signature of m6A/m5C Regulated Genes in Early-Stage Lung Adenocarcinoma
por: Tian, Long, et al.
Publicado: (2023)

Mid-term results of completely portal robotic lobectomy for stage I & II non-small cell lung cancer
por: Ong, Kingsfield, et al.
Publicado: (2020)

Radiomics Signature as a Predictive Factor for EGFR Mutations in Advanced Lung Adenocarcinoma
por: Hong, Duo, et al.
Publicado: (2020)

Prognostic analysis and risk stratification of lung adenocarcinoma undergoing EGFR-TKI therapy with time-serial CT-based radiomics signature
por: Zhang, Xiaobo, et al.
Publicado: (2022)

Prognostic value of MMP9 activity level in resected stage I B lung adenocarcinoma
por: Yu, Yongfeng, et al.
Publicado: (2016)

Prognostic Value of Inflammatory Biomarkers in Patients With Stage I Lung Adenocarcinoma Treated With Surgical Dissection
por: Shen, Yu-Jia, et al.
Publicado: (2021)

The predictive value of [(18)F]FDG PET/CT radiomics combined with clinical features for EGFR mutation status in different clinical staging of lung adenocarcinoma
por: Gao, Jianxiong, et al.
Publicado: (2023)

Radiomics: a potential biomarker for N2 malignancy in clinical stage I lung adenocarcinoma
por: Deng, Jiajun, et al.
Publicado: (2020)

Potential Prognostic Value and Mechanism of Stromal-Immune Signature in Tumor Microenvironment for Stomach Adenocarcinoma
por: Zhu, Xinying, et al.
Publicado: (2020)

A five-gene expression signature of centromeric proteins with prognostic value in lung adenocarcinoma
por: Wang, Yangwei, et al.
Publicado: (2023)

Thoracoscopic completion right lower lobectomy after anteromedial basilar segmentectomy in early‐stage lung cancer
por: Liu, Yu‐Wei, et al.
Publicado: (2019)

An integrated analysis of prognostic mRNA signature in early- and progressive-stage gastric adenocarcinoma
por: Hong, Xiaoling, et al.
Publicado: (2023)

Radiomics signature on CECT as a predictive factor for invasiveness of lung adenocarcinoma manifesting as subcentimeter ground glass nodules
por: Chen, Wufei, et al.
Publicado: (2021)

Independent prognostic value of fascin immunoreactivity in stage III–IV colonic adenocarcinoma
por: Puppa, G, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_8reevg713lic3j8udpqi2s4ea9